FAQs
Platform & Technology
What is EndoDNA?
A patented genomic interpretation engine that analyzes biological pathways rather than isolated SNPs.
What is BIOS?
A clinical intelligence layer that translates genomic data into structured, actionable insights.
How EndoDNA differ from consumer DNA tests?
Consumer reports summarize traits. EndoDNA models biological pathways and provides structured clinical interpretation.
Is EndoDNA a diagnostic test?
No. It is a clinical decision-support platform designed to assist clinicians in interpreting genomic tendencies.
What does pathway-level modeling mean?
Pathway-level modeling evaluates how multiple genes interact within biological systems, such as hormone metabolism or inflammatory signaling, rather than analyzing single variants in isolation.
What biological systems does EndoDNA analyze?
The platform analyzes hormone regulation, metabolic efficiency, inflammatory signaling, detoxification capacity, neurotransmitter pathways, and other interconnected biological systems.
Does the platform analyze SNPs?
Yes, but SNPs are interpreted within the context of broader biological pathways rather than presented as isolated findings.
What does model-agnostic AI mean?
Model-agnostic AI means the platform can leverage advanced language models while remaining independent of any single provider, ensuring adaptability and future-proofing.
Is BIOS an AI chatbot?
No. BIOS is a structured clinical intelligence layer that uses model-agnostic AI to generate pathway-based insights, not open-ended chatbot responses.
Can patients access BIOS directly?
The platform is clinician-first. Patients receive structured explanations through their provider.
Clinical Use
How does EndoDNA support clinical decision-making?
It provides structured pathway summaries, intervention considerations, and patient-friendly explanations that reduce interpretation burden and improve consult efficiency.
Does this replace lab testing?
No. Labs show current physiology, while genomics reveals predisposition patterns that inform long-term strategy.
Can this help with hormone optimization?
Yes. The platform evaluates genetic tendencies influencing estrogen metabolism, androgen signaling, cortisol regulation, and related pathways.
Can EndoDNA assist with metabolic dysfunction?
Yes. It analyzes pathways related to insulin signaling, mitochondrial efficiency, inflammatory load, and adipocyte regulation.
Is this appropriate for menopause care?
Yes. It provides pathway-level insights into estrogen metabolism, inflammation, detoxification, and metabolic cross-talk relevant to midlife health.
How long does interpretation take?
BIOS generates structured output efficiently, reducing manual SNP review and shortening consult preparation time.
Does this prescribe medication?
No. It provides decision-support guidance but does not prescribe medication or override clinical authority.
Can this be used in telehealth models?
Yes. The platform is structured to support direct-pay, telehealth, and membership-based practices.
Does it reduce trial-and-error treatment?
It provides biological context that may help clinicians personalize protocols more efficiently.
Can it identify dosing sensitivities?
The platform may highlight genetic tendencies that influence metabolism or clearance pathways relevant to dosing considerations.
AI & Data
How is AI used in the platform?
AI enhances interpretation and generates structured summaries based on pathway-level genomic analysis.
Is this a black-box model?
No. The platform is built on structured biological logic with transparent pathway modeling.
Is patient data sold?
No. The platform does not sell patient data.
Is EndoDNA HIPAA compliant?
Compliance posture and security protocols are designed to align with healthcare data protection standards.
How is data protected?
Data is encrypted, securely stored, and handled under strict privacy policies.
Does AI make autonomous medical decisions?
No. The platform supports clinicians but does not make independent medical decisions.
Can genomic data be deleted upon request?
Data handling policies include patient rights and privacy protections.
Are outputs standardized across providers?
The platform ensures structured consistency while allowing clinician interpretation.
Does BIOS integrate with EHR systems?
Integration capabilities depend on implementation and API configuration.
Solutions
Can this help patients with normal labs but persistent symptoms?
Yes. Pathway-level genomics can provide deeper biological context beyond standard lab panels.
Can this support longevity practices?
Yes. It analyzes oxidative stress, inflammatory regulation, and metabolic resilience pathways.
Is this useful for TRT clinics?
Yes. It supports interpretation of androgen signaling and metabolic cross-talk.
Can it support supplement personalization?
It provides pathway context that may inform personalized supplementation strategies.
Does it analyze detox pathways?
Yes. Detoxification gene networks are evaluated at the pathway level.
Can it help with inflammation-related concerns?
The platform models inflammatory signaling pathways and genetic predispositions.
Is this useful for integrative medicine providers?
Yes. It aligns with root-cause and systems-based approaches to care.
Can it help explain fatigue or brain fog?
It may reveal pathway-level tendencies across hormones, metabolism, and neurotransmitter systems.
Does this guarantee improved outcomes?
No. It supports informed decision-making but does not guarantee outcomes.
Business & Implementation
How long does onboarding take?
Onboarding timelines vary based on practice size and integration needs.
What types of practices is this best for?
Functional, integrative, hormone optimization, longevity, and direct-pay practices benefit most.
Is training provided?
Yes. Training resources are available for clinicians and staff.
Can practices resell DNA panels?
Yes. Revenue-aligned models may include panel resale and upgrade options.
Does this create recurring revenue opportunities?
Yes. Subscription access and panel integration can support recurring revenue models.
Is there a minimum clinic size required?
Implementation is flexible for solo providers or multi-clinic groups.
Can the platform be white-labeled?
Yes. It aligns with root-cause and systems-based approaches to care.
Does it support multi-provider organizations?
Yes. Structured outputs help standardize interpretation across teams.
Does it support multi-provider organizations?
Yes. Structured outputs help standardize interpretation across teams.
Is there API access available?
API access may be available for integration partnerships.
Who is this not for?
The platform is not intended for direct-to-consumer novelty testing companies or purely rule-based SNP reporting tools.